Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New study targets immune chaos in long COVID POTS

NCT ID NCT07189936

First seen Nov 01, 2025 · Last updated Apr 30, 2026 · Updated 23 times

Summary

This study looks at why some people with Long COVID develop a condition called POTS, which causes a fast heartbeat and fatigue when standing. Researchers want to see if a drug called 2-HOBA can reduce harmful immune activity in the body. About 50 adults with Long COVID POTS will take either the drug or a placebo for 28 days to measure changes in immune cells and blood flow.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SARS-COV-2 INFECTION are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Cyndya Shibao

    RECRUITING

    Nashville, Tennessee, 37027, United States

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.